MedTrace Logo

Comparative Study of the VeraCept Low-Dose Intrauterine Copper Contraceptive vs. the TCu380 Copper IUD

NCT02167763 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-04-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of the VeraCept Low Dose Intrauterine Copper Contraceptive compared to the standard T shaped copper IUD, the TCu380.

Conditions

  • Prevention of Pregnancy

Interventions

DEVICE

VeraCept Intrauterine Copper Contraceptive

DEVICE

TCu380 IUD

Sponsors & Collaborators

  • Sebela Women's Health Inc.

    lead INDUSTRY

Principal Investigators

  • Juan M. Canela, M.D. · Clinica Canela

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2017-12-31

Countries

  • Dominican Republic

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02167763 on ClinicalTrials.gov